consent detailed history was taken and records reviewed followed by physical examination to fulfill the exclusion criteria. Patients with a history of previous STEMI, percutaneous intervention or coronary artery bypass graft surgery, congenital heart disease, cardiac failure, cardiomyopathy, chronic liver or kidney disease, malignancy, diabetic retinopathy, cataracts, retinitis pigmentosa, pan retinitis, maculopathies, conjunctivitis, and other conjunctival diseases like pterygium and history of retinal photocoagulation were excluded from the study.
Patients were enrolled in this cohort study from June 2016 to December 2017 on the basis of successful thrombolysis after acute STEMI. These patients were observed for one month after inclusion in the cohort for primary endpoints, i.e. a composite of re-myocardial infarction, stroke, death and re-hospitalisation secondary to cardiogenic shock (CS), left ventricular failure (LVF), heart block, arrhythmia and ventricular septal rupture (VSR) or any of the above complications alone. Secondary endpoints were defined as a composite of the above complications or alone, occurring after one month till four months.
Data regarding baseline variables including age, gender, comorbid conditions, type of MI, systolic blood pressure (SBP), diastolic blood pressure (DBP), highly sensitiveTroponin T, lipid profile at the time of admission, and medicines used for hypertension, were recorded. Fundoscopy was performed by two residents of cardiology for all the included patients under the supervision of a consultant ophthalmologist. The patients were categorised into 4 groups: no HR, mild HR (mild focal narrowing of vessels), moderate HR (diffuse narrowing of vessels with AV nipping, cotton wool spots and hemorrhages), and severe HR (papilloedema), on the basis of classification proposed by Keith et al. 11 Successful thrombolysis was defined as at least 50% resolution of ST elevations in ECG at 90 minutes of initiating the streptokinase infusion. Patients were followed on monthly basis for four months in outpatient department with review of records and a thorough examination followed by appropriate investigations, if needed, including ECG, echocardiography, chest X-ray, and CT brain to look for any complications.
Data regarding re-hospitalisation was obtained by interview and reviewing records. All the above mentioned information were recorded in a pre-designed proforma. All data were analysed with SPSS version 20.0. Mean ±SD was calculated for continuous variables. Frequencies and percentages were calculated for categorical variables. Association between hyper-tensive retinopathy and different complications was calculated by using Chi-Square test. Relative risk was calculated by using regression model. Kaplan-Meier survival curve was drawn for overall incidence of complications over four months and for death. A p-value of <0.05 was taken as significant.
RESULTS
A total of 118 patients were recruited in the study with mean age of 54.83 ±8.6 years, of which 49.2% (n=58) were males. The mean duration of hypertension was 8.2 ±2.7 years. Mean SBP and DBP were 132.7 ±36.2 and 90.1 ±18.7 mmHg, respectively. Fifty-eight (49.2%) patients were on calcium channel blockers, 33.1% (n=39) on angiotensin converting enzyme inhibitors/ angiotensin receptor blockers, 9.3% (n=11) on beta blockers, and 8.4% (n=10) were using a combination therapy for BP control. Baseline characteristics of the included patients are given in Table I .
Primary composite endpoints at one month were achieved in 3.7% (n=1) of patients in mild HR group, 8% (n=2) of patients in moderate HR group, and 19% (n=4) Table III . Multivariate analysis for association between HR and post STEMI complication rates in successfully thrombolysed patients with multiple comorbid conditions is shown in Table IV . It showed that HR was associated with post STEMI complication rates (p<0.001) independent of gender, diabetes and smoking, and family history.
Kaplan-Meier curve was plotted for survival of patients with HR for death as well as for complications. Death and complications increased while the survival decreased with the increase in stage of HR (Figures 1 and 2) .
DISCUSSION
Hypertension has become the leading risk factor for cardiovascular disease worldwide. 12 Despite the rising trend towards hypertension awareness ranging from 72% in US to 62% in Australia, the BP control rates remained discouraging at 35% and 24%, respectively. In South Asian countries like China and India, the reported control rates were 8% and 6%, respectively. 2 Control rates vary according to geographic region. 13, 14 National Health Survey of Pakistan reported an overall 18% of adults and 33% of adults above 45 years of age are hypertensive. It also stated that only 50% of hypertensive individuals were diagnosed and only half of those hypertensive individuals were on treatment. Previous studies have demonstrated the relationship between HR and cardiovascular disease. 7, 15, 16 Retinal artery thickening had been associated with fibrous nodules formation and fibrinous degeneration in cerebral vessels. 17 Association between retinal arteriolar-venular ratio and carotid intimal thickness had also been established in a study. 18 Duncan et al. reported a twofold increase in cardiovascular disease with HR. 19 Wong et al. in his case control study reported 1.8 times increased odds of coronary artery disease with HR. 20 Atherosclerosis risk in communities (ARIC) documented 2.6 times increased risk of stroke with HR. 21 The present study is unique in a sense that the association between HR and post-STEMI complications in successfully thrombolysed patients is documented. So far, the studies available were regarding new incidence of cardio-vascular disease and its relationship with HR or association of HR with angiographic severity of coronary artery disease. The present results were quite promising and demonstrated a very strong association between HR and post STEMI complications in successfully thrombolysed patients. Moreover, the incidence of post STEMI complications progressively increased from no HR to severe HR group. The overall death rate also increased while moving from no to severe HR. The strengths of the study were its prospective cohort design, appropriate follow-up, and adequate sample size. However, the main limitation of this study was that fundoscopy was performed with a hand-held ophthalmoscope, which is not the gold standard.
So far, limited data was available regarding reversal of HR changes. However, studies are needed to be done to see whether reversal of HR reduces the risk of coronary artery disease and complications after acute coronary events or not.
CONCLUSION
HR was an independent risk factor for complications after successful thrombolysis of acute STEMI. HR also increased the relative risk of primary and secondary endpoints. Patients with acute STEMI should be routinely screened for HR to identify high risk individuals for early aggressive interventional management.
